Dr Saurabh Sethi, an experienced gastroenterologist and gut health expert, shared insights into these eight powerful ...

Biotech insiders tout antibody-drug conjugates as the next big thing in cancer treatment, with firms urged to pursue global ...

Former President Joe Biden urged Americans to stay optimistic and not to check out in response to what he says are attacks on ...

GSK plc ( NYSE: GSK) and Syndivia on Monday announced an agreement granting GSK exclusive worldwide rights to develop and ...

Former President Joe Biden, in his first public address since finishing prostate cancer treatment, urged “optimism” in a time ...

Fresh from a European cancer conference that was all about antibody-drug conjugates (ADCs), GSK has turned to French biotech ...

GSK said it acquired exclusive worldwide rights for a drug candidate targeting prostate cancer from France's Syndivia for up to 268 million pounds ($356.8 million).

Men whose prostate cancer returns after surgery or radiation therapy may now have a new, life-extending treatment option. A ...

Prostate cancer survivors Mark V. Williamson and Jim East will celebrate with other men who beat the disease, Nov. 16 at the ...

The combination of niraparib and abiraterone halves the spread of prostate cancer in men with BRCA gene mutations.

Florida Atlantic University’s Black Student Union hosted its annual competition, the Battle of the Sexes, a talent show where ...

Breast changes in men are common. Sometimes it’s fat. Sometimes it’s breast tissue growth. Rarely, it’s cancer.